GSK collaborates closely with Canadian sites — such as hospitals and other health-care centres — to operationalize its trials ...
The top UN health official gave a sobering reality check as the Fourth Global High-Level Ministerial Meeting on Antimicrobial ...
India's Pinaka multi-barrel rocket launcher system is being exported to Armenia. The French military is also considering ...
GE HealthCare's AI initiatives, including AI-powered imaging solutions and strategic partnerships, are led by its chief AI ...
A revolutionary new medical test could make it even easier for doctors to figure out what sickness is ailing you.
Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).